Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Rice

Showing results (1071-1080 of 2,031) with videos related to

Pageof 204
Sort By:
Journal of Medicinal Chemistry|May 1, 1986
Probes for narcotic receptor mediated phenomena. 9. Synthesis of (+/-)-(3 alpha,6a alpha,11a beta)-1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a- methanobenzofuro[2,3-c]azocin-10-ol, an oxide-bridged 5-(m-hydroxyphenyl)morphanT R Burke, A E Jacobson, K C Rice, et al.
Annals of the New York Academy of Sciences|November 21, 2000
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addictionR B Rothman, J S Partilla, C M Dersch, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909)Y Zhang, R B Rothman, C M Dersch, et al.
The Journal of Urology|October 1, 1988
Measurement of impotence by laser Doppler flowmetry and conventional methodologyB E Cahill, E V Ross, R W Pielet, et al.
Acta Chirurgica Scandinavica|January 1, 1976
Liver blood flow measurement the interpretation of xenon133 clearance curvesR J Mackenzie, D P Leiberman, R T Mathie, et al.
Cancer Research|January 1, 1996
Lisofylline inhibits transforming growth factor beta release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in miceE Clarke, G C Rice, R S Weeks, et al.
Journal of Clinical Microbiology|July 10, 2004
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller, S A Messer, L Boyken, et al.
Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.
Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.
Molecular Pharmacology|April 1, 1991
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935S P Berger, R E Martenson, P Laing, et al.
Pageof 204

Showing results (1071-1080 of 2,031) with videos related to

Sort By:
Pageof 204
Journal of Medicinal Chemistry|May 1, 1986
Probes for narcotic receptor mediated phenomena. 9. Synthesis of (+/-)-(3 alpha,6a alpha,11a beta)-1,3,4,5,6,11a-hexahydro-2-methyl-2H-3,6a- methanobenzofuro[2,3-c]azocin-10-ol, an oxide-bridged 5-(m-hydroxyphenyl)morphanT R Burke, A E Jacobson, K C Rice, et al.
Annals of the New York Academy of Sciences|November 21, 2000
Methamphetamine dependence: medication development efforts based on the dual deficit model of stimulant addictionR B Rothman, J S Partilla, C M Dersch, et al.
Journal of Medicinal Chemistry|December 22, 2000
Synthesis and transporter binding properties of bridged piperazine analogues of 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine (GBR 12909)Y Zhang, R B Rothman, C M Dersch, et al.
The Journal of Urology|October 1, 1988
Measurement of impotence by laser Doppler flowmetry and conventional methodologyB E Cahill, E V Ross, R W Pielet, et al.
Acta Chirurgica Scandinavica|January 1, 1976
Liver blood flow measurement the interpretation of xenon133 clearance curvesR J Mackenzie, D P Leiberman, R T Mathie, et al.
Cancer Research|January 1, 1996
Lisofylline inhibits transforming growth factor beta release and enhances trilineage hematopoietic recovery after 5-fluorouracil treatment in miceE Clarke, G C Rice, R S Weeks, et al.
Journal of Clinical Microbiology|July 10, 2004
Cross-resistance between fluconazole and ravuconazole and the use of fluconazole as a surrogate marker to predict susceptibility and resistance to ravuconazole among 12,796 clinical isolates of Candida sppM A Pfaller, S A Messer, L Boyken, et al.
Neuropeptides|May 1, 1984
Ionic conditions differentially affect 3H-DADL binding to type-I and type-II opiate delta receptors in vitroR B Rothman, J A Danks, C B Pert, et al.
Neuropeptides|June 1, 1984
Tritiated-6-beta-fluoro-6-desoxy-oxymorphone: a highly selective ligand for the opiate mu receptor whose binding is characterized by low nonspecific bindingR B Rothman, J A Danks, A E Jacobson, et al.
Molecular Pharmacology|April 1, 1991
Photoaffinity labeling of the dopamine reuptake carrier protein with 3-azido[3H]GBR-12935S P Berger, R E Martenson, P Laing, et al.
Pageof 204